A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery

To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS). Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery. Survey administrati...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of ophthalmology Vol. 266; pp. 313 - 320
Main Authors:	Hays, Ron D., Tarver, Michelle E., Eydelman, Malvina, Spaeth, George L., Parke, David W., Singh, Kuldev, Nguyen, Don, Saltzmann, Robert M., Smith, Oluwatosin, Shaw, My Le, Rosenberg, Lisa, Seibold, Leo, Teymoorian, Savak, Provencher, Lorraine M., Bicket, Amanda K., Arora, Nitika, Junk, Anna K., Chaya, Craig, Salim, Sarwat, Kuo, Debbie, Weiner, Asher, Zhang, Ze, Rhee, Brian Francis Douglas, McMillan, Brian, Choo, Clara, Garris, Winston, Noecker, Rob, Fellman, Ronald, Caprioli, Joseph, Vold, Steven, Pasquale, Louis, Cui, Qi, Mbagwu, Michael
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-10-2024
Subjects:	symptoms patient-reported outcomes MIGS cataract surgery
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS). Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery. Survey administration was on a computer, iPad, or similar device. 184 adults completed the baseline survey, 124 a survey 3 months after surgery, and 106 the 1-month test-retest reliability survey. The age range was 37 to 89 (average age = 72). Most were female (57%), non-Hispanic White (81%), and had a college degree (56%). The Glaucoma Outcomes Survey (GOS) assesses functional limitations (27 items), vision-related symptoms (7 items), psychosocial issues (7 items), and satisfaction with microinvasive glaucoma surgery (1 item). These multiple-item scales were scored on a 0 to 100 range, with a higher score indicating worse health. Internal consistency reliability estimates ranged from 0.75 to 0.93, and 1-month test-retest intraclass correlations ranged from 0.83 to 0.92 for the GOS scales. Product-moment correlations among the scales ranged from 0.56 to 0.60. Improvement in visual acuity in the study eye from baseline to the 3-month follow-up was significantly related to improvements in GOS functional limitations (r = 0.18, P = .0485), vision-related symptoms (r = 0.19, P = .0386), and psychosocial concerns (r = 0.18, P = .0503). Responders to treatment ranged from 17% for vision-related symptoms to 48% for functional limitations. This study supports using the GOS for ophthalmic procedures such as MIGS. Further evaluation of the GOS in different patient subgroups and clinical settings is needed.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
ISSN:	0002-9394 1879-1891 1879-1891
DOI:	10.1016/j.ajo.2024.05.031